Dr. Saloni Wagh & Ms. Shivani Wagh of Supriya Lifescience Featured in 2025 Candere Hurun India Women Leaders List

0
10

In a proud moment for Indian industry, Dr. Saloni Wagh, Managing Director, and Ms. Shivani Wagh, Joint Managing Director of Supriya Lifescience Ltd., have been featured in the prestigious 2025 Candere Hurun India Women Leaders List. The list, a collaboration between Candere and Hurun India, honors 95 of the nation’s most influential women leaders who are redefining business, leadership, and social impact.

Dr. Saloni Wagh & Ms. Shivani Wagh of Supriya Lifescience Featured in 2025 Candere Hurun India Women Leaders List

This year’s theme, “Celebrating Women Creating Opportunities,” aligns perfectly with the leadership values of both honorees. Their recognition reflects a journey marked by perseverance, innovation, and a deep commitment to purpose. Under their dynamic leadership, Supriya Lifescience has emerged as a global pharmaceutical leader, known for its excellence in sustainable healthcare solutions.

Dr. Saloni Wagh said,
“Leading in the pharmaceutical sector requires a vision that blends innovation with responsibility. Our mission goes beyond business growth—it’s about creating sustainable solutions that improve lives globally. This recognition motivates us to keep pushing boundaries and building a culture where every challenge becomes an opportunity for impact.”

Ms. Shivani Wagh shared, “This honor is for every woman who dares to lead and every team member who drives progress. At Supriya Lifescience, we’re united by a shared vision—to advance global healthcare while nurturing people and partnerships. It’s a privilege to be part of a list that recognizes purpose and progress.”

The 2025 Candere Hurun India Women Leaders List highlights women who have created over ₹2 lakh crore in self-made wealth and led enterprises worth more than ₹12 lakh crore. It stands as a benchmark for excellence in women’s leadership across business, philanthropy, and economic transformation.

The dual recognition of Dr. Saloni Wagh and Ms. Shivani Wagh not only underscores their individual achievements but also their shared commitment to Supriya Lifescience’s sustained growth. FY25 marked a historic year for the company, with record revenues of ₹696.48 crore, representing a 22% year-on-year growth. Their visionary leadership continues to drive purpose-led innovation, diversity, and global success.